Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Brain Neoplasms 31Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Lung Neoplasms 20Neoplasm Metastasis 19Melanoma 12Breast Neoplasms 12Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 5Colorectal Neoplasms 5Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3NSCLC 3Meningioma 3Hematologic Neoplasms 3Gastrointestinal Neoplasms 3Uveal Melanoma 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Sarcoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

pembrolizumab 66Cisplatin 40Carboplatin 25Cetuximab 23Magnetic Resonance Spectroscopy 19Paclitaxel 18Nivolumab 17Specimen Handling 16Radiotherapy, Intensity-Modulated 16Radiotherapy 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Fluorouracil 9Taxes 8Biopsy 8atezolizumab 6cemiplimab 5Surgical Procedures, Operative 5Radiation 5Ipilimumab 5(225)Ac-DOTA-c(RGDyK) 5dostarlimab 4Standard of Care 4Immunoglobulin G 4Immune Checkpoint Inhibitors 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Radiosurgery × 90 days × Clear all
NCT07156227 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
39 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04938609 2026-04-09

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Providence Health & Services

Phase 2 Active not recruiting
28 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06211335 2026-03-12

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

University of California, Davis

Phase 1 Recruiting
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡